Redwood City, CA, United States of America

Sean Matthew West

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean Matthew West. Retrieved from https://idiyas.com/inventor/sean-matthew-west

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sean Matthew West: Innovator in Antibody Modification

Introduction

Sean Matthew West is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of antibody modification. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Sean holds a patent titled "Antibodies Modified for Transglutaminase Conjugation, Conjugates Thereof, and Methods and Uses." This patent highlights his expertise in creating modified antibodies that can be utilized in therapeutic contexts. He has 1 patent to his name, reflecting his innovative approach to solving complex biological challenges.

Career Highlights

Sean is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role there allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through advanced therapeutic solutions.

Collaborations

Throughout his career, Sean has collaborated with talented individuals such as Pavel Strop and Chetana Rao-Naik. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

In summary, Sean Matthew West is a distinguished inventor whose work in antibody modification is paving the way for advancements in medical therapies. His contributions to the field are invaluable, and his ongoing research continues to inspire innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…